Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Koshi Yokomura"'
Autor:
Noriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Hyogo Naoi, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Mikio Toyoshima, Masato Kono, Shiro Imokawa, Masato Fujii, Taisuke Akamatsu, Naoki Koshimizu, Koshi Yokomura, Hiroyuki Matsuda, Yusuke Kaida, Yutaro Nakamura, Masahiro Shirai, Kazutaka Mori, Masafumi Masuda, Tomoyuki Fujisawa, Naoki Inui, Hiroaki Sugiura, Hiromitsu Sumikawa, Masashi Kitani, Kazuhiro Tabata, Noriyoshi Ogawa, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial pneumonia (IIP). Howev
Externí odkaz:
https://doaj.org/article/d38798487a204e818e149454dbc5d89e
Autor:
Yuzo Suzuki, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Koshi Yokomura, Shiro Imokawa, Takafumi Suda, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hirotsugu Hasegawa
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Background Idiopathic pleuroparenchymal fibroelastosis (iPPFE), a progressive fibrotic disease, is characterised by upper lobe–dominant lung fibrosis involving the pleura and subpleural lung parenchyma. However, no prognostic markers have been esta
Externí odkaz:
https://doaj.org/article/d4f06b1607cd407a9add5c0e87c114fd
Autor:
Yorihide Yanagita, Shinichi Arizono, Yuichi Tawara, Masaki Oomagari, Hikaru Machiguchi, Koshi Yokomura, Norimasa Katagiri, Yuki Iida
Publikováno v:
The Clinical Respiratory Journal, Vol 16, Iss 7, Pp 522-532 (2022)
Abstract Introduction Aspiration pneumonia is a common problem among older adults; it has a high mortality rate and the prevalence is increasing. Reports on the risk factors for mortality in patients with aspiration pneumonia are limited. This study
Externí odkaz:
https://doaj.org/article/d8b32696d5004cfab7d3466f0cf55209
Autor:
Yuko Tanaka, Yuzo Suzuki, Hirotsugu Hasegawa, Koshi Yokomura, Atsuki Fukada, Yusuke Inoue, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background The assessment of lung physiology via pulmonary function tests (PFTs) is essential for patients with idiopathic pulmonary fibrosis (IPF). However, PFTs require active participation, which can be challenging for patients with sever
Externí odkaz:
https://doaj.org/article/5f1be262f8d4438abe4a97dae26dfaa1
Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis
Autor:
Yuzo Suzuki, Atsuki Fukada, Kazutaka Mori, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Shiro Imokawa, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is characterised by upper lobe-dominant fibrosis involving the pleura and subpleural lung parenchyma, with advanced cases often complicated by progressive weight loss. Therefore, we hypot
Externí odkaz:
https://doaj.org/article/73ec037f13204ed99b126dbcaadb79e3
Autor:
Yorihide Yanagita, Shinichi Arizono, Yuichi Tawara, Masaki Oomagari, Hikaru Machiguchi, Koshi Yokomura, Norimasa Katagiri, Yuki Iida
Publikováno v:
Journal of International Medical Research, Vol 51 (2023)
Objective To evaluate the factors that influence walking ability in patients hospitalized due to aspiration pneumonia. Methods This retrospective observational study evaluated patients hospitalized with aspiration pneumonia. The primary endpoint was
Externí odkaz:
https://doaj.org/article/1e1b11d262c248df9c90106580b6c776
Autor:
Takafumi Koyauchi, Yuzo Suzuki, Kazuki Sato, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Shiro Imokawa, Hidenori Nakamura, Tatsuya Morita, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Respiratory modalities applied at the end of life may affect the burden of distressing symptoms and quality of dying and death (QODD) among patients with end-stage interstitial lung disease (ILD); however, there have been few stud
Externí odkaz:
https://doaj.org/article/486276099272449ead0608b524843724
Autor:
Hironao Hozumi, Masato Kono, Hirotsugu Hasegawa, Shinpei Kato, Yusuke Inoue, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute exacerbation (AE)—a rapidly progressing and deadly respirat
Externí odkaz:
https://doaj.org/article/a8897a8aab0f430daf446a88dfc21706
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been ev
Externí odkaz:
https://doaj.org/article/e4053b1dc1be411488281f1878f5b551
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Currently, there are two antifibrotics used to treat idiopathic pulmonary fibrosis (IPF): pirfenidone and nintedanib. Antifibrotics slow disease progression by reducing the annual decline of forced vital capacity (FVC), which poss
Externí odkaz:
https://doaj.org/article/4dbda5c1c00342a09b5cd06cd44651aa